Kindal Andrews
Family · Corpus Christi, TXNPI 1083067631
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $793 and has fallen 76.3% since, to $188 in 2025.
Across 67 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$191
- Lilly USA, LLC$104
- AbbVie$98
- Boehringer Ingelheim$88
- AstraZeneca$68
- GSK$54
- plus $451 from 17 others
What the payments were for
- Food & beverage$1,054100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $191 |
| Lilly USA, LLC | 6 | $104 |
| AbbVie | 5 | $98 |
| Boehringer Ingelheim | 5 | $88 |
| AstraZeneca | 4 | $68 |
| GSK | 3 | $54 |
| Neurocrine Biosciences, Inc. | 1 | $43 |
| Pfizer | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $36 |
| Acerus Pharmaceuticals Corporation | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $27 |
| Merck | 2 | $26 |
| Eisai Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Bayer | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Sanofi | 1 | $14 |
How this compares
$1,054 in reported general payments places this provider in the 70th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 21 | $168 |
| Lisinopril | 12 | $84 |
| Amlodipine Besylate | 14 | $73 |
Paid to pharmacies, not to this prescriber.
Other family in Corpus Christi
- Stephanie RodriguezCorpus Christi$159K
- Katie MontgomeryCorpus Christi$29K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.